{"url_path":"/sec/ivvd/8-k/2026-07-06/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-06","source_url":"https://www.sec.gov/Archives/edgar/data/1832038/0001193125-26-295539-index.html","accession_number":"0001193125-26-295539","cik":"0001832038","ticker":"IVVD","issuer_name":"Invivyd, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1832038/0001193125-26-295539-index.html","primary_entity_key":"0001832038","primary_entity_name":"Invivyd, Inc."},"word_count":69,"has_tables":true,"body_markdown":"Item 8.01 Other Events.\n\n \n\nOn July 6, 2026, Invivyd, Inc. issued a press release entitled “Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA.” A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01."}